These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 26209838)

  • 21. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.
    Rabe IB; Miller ER; Fischer M; Hills SL
    Vaccine; 2015 Jan; 33(5):708-12. PubMed ID: 25498208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.
    Baker MA; Nguyen M; Cole DV; Lee GM; Lieu TA
    Vaccine; 2013 Dec; 31 Suppl 10():K98-112. PubMed ID: 24331080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.
    Moro PL; Woo EJ; Paul W; Lewis P; Petersen BW; Cano M
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004846. PubMed ID: 27410239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Haber P; Moro PL; Ng C; Dores GM; Lewis P; Cano M
    Vaccine; 2019 Mar; 37(11):1516-1520. PubMed ID: 30739795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
    Moro PL; Arana J; Marquez PL; Ng C; Barash F; Hibbs BF; Cano M
    Vaccine; 2019 Jun; 37(28):3730-3734. PubMed ID: 31155414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017.
    Landazabal CS; Moro PL; Lewis P; Omer SB
    Vaccine; 2019 Feb; 37(9):1229-1234. PubMed ID: 30660400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
    Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011-July 2018.
    McNeil MM; Paradowska-Stankiewicz I; Miller ER; Marquez PL; Seshadri S; Collins LC; Cano MV
    Vaccine; 2019 Oct; 37(44):6760-6767. PubMed ID: 31548014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).
    Niu MT; Rhodes P; Salive M; Lively T; Davis DM; Black S; Shinefield H; Chen RT; Ellenberg SS
    J Clin Epidemiol; 1998 Jun; 51(6):503-10. PubMed ID: 9635999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.
    Hibbs BF; Moro PL; Lewis P; Miller ER; Shimabukuro TT
    Vaccine; 2015 Jun; 33(28):3171-8. PubMed ID: 25980429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced Clinical Decision Support for Vaccine Adverse Event Detection and Reporting.
    Baker MA; Kaelber DC; Bar-Shain DS; Moro PL; Zambarano B; Mazza M; Garcia C; Henry A; Platt R; Klompas M
    Clin Infect Dis; 2015 Sep; 61(6):864-70. PubMed ID: 26060294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome.
    Miller ER; McNeil MM; Moro PL; Duffy J; Su JR
    Vaccine; 2020 Nov; 38(47):7458-7463. PubMed ID: 33039207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013.
    Moro PL; Arana J; Cano M; Lewis P; Shimabukuro TT
    Clin Infect Dis; 2015 Sep; 61(6):980-7. PubMed ID: 26021988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety.
    Iskander JK; Miller ER; Chen RT
    Pediatr Ann; 2004 Sep; 33(9):599-606. PubMed ID: 15462575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.
    Moro PL; Haber P; McNeil MM
    Expert Rev Vaccines; 2019 Oct; 18(10):1091-1101. PubMed ID: 31580725
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016.
    Walker WL; Hills SL; Miller ER; Fischer M; Rabe IB
    Vaccine; 2018 Jul; 36(29):4369-4374. PubMed ID: 29891351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
    Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
    Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System.
    Ball R; Halsey N; Braun MM; Moulton LH; Gale AD; Rammohan K; Wiznitzer M; Johnson R; Salive ME;
    J Clin Epidemiol; 2002 Aug; 55(8):819-24. PubMed ID: 12384197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.